	PSI CRO has chosen goBALTO's suite of SSU applications for all their studies on a worldwide basis to further boost their clinical study startup process. With the use of this new Select application, PSI CRO hopes that it will assist with site identification, feasibility assessment, and selection of investigative sites. Due to the adaption of these new technologies, PSI CRO will be on the right track to success within clinical trials.